Related Experiment Video
Updated: Sep 25, 2025

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO
Bahadir Simsek1, Spyridon Kostantinis1, Judit Karacsonyi1
1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Insights
About 8.5% of chronic total occlusion (CTO) percutaneous coronary interventions (PCI) involve balloon undilatable lesions. These challenging cases have lower success rates and increased risk of major adverse cardiovascular events (MACE).
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Devices
Background:
- Balloon undilatable lesions are a significant challenge in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
- Limited research exists on the prevalence, treatment strategies, and clinical outcomes associated with these difficult-to-treat lesions.
Purpose of the Study:
- To investigate the clinical characteristics of patients with balloon undilatable lesions during CTO PCI.
- To evaluate the procedural outcomes and identify factors associated with success and complications in this patient subset.
Main Methods:
- Analysis of data from the Prospective Global Registry for the Study of CTO Intervention (PROGRESS-CTO) database (NCT02061436).
- Inclusion of 6535 CTO PCI cases performed between 2012 and 2022.
- Comparison of patient demographics, comorbidities, lesion characteristics, interventional techniques, and in-hospital outcomes between balloon undilatable lesions and others.
Main Results:
- Balloon undilatable lesions were identified in 8.5% (558/6535) of CTO PCIs.
- Patients with undilatable lesions were older and had a higher prevalence of diabetes, prior PCI, myocardial infarction, and coronary artery bypass graft surgery.
- Treatment of undilatable lesions was associated with lower technical success (90.9% vs. 93.8%) and a higher incidence of in-hospital major adverse cardiovascular events (MACE) (5.0% vs. 1.3%).
Conclusions:
- Approximately 1 in 12 CTO lesions present as balloon undilatable, posing a significant challenge.
- The management of balloon undilatable lesions is linked to reduced technical success rates and increased in-hospital MACE.
- Further research into optimal strategies for these complex lesions is warranted.
Background:
The prevalence, treatment, and outcomes of balloon undilatable lesions encountered in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have received limited study.
Methods:
We examined the clinical characteristics and procedural outcomes of balloon undilatable lesions in the Prospective Global Registry for the Study of CTO Intervention (PROGRESS-CTO, NCT02061436).
Results:
Of 6535 CTO PCIs performed between 2012 and 2022, 558 (8.5%) lesions were balloon undilatable. In this subset, patients were older (mean age 67 ± 10 vs. 64 ± 10, p < 0.001) and had higher prevalence of comorbidities: diabetes mellitus (54% vs. 40%, p < 0.001), prior PCI (71% vs. 59%, p < 0.001), prior myocardial infarction (52% vs. 45%, p = 0.003), and prior coronary artery bypass graft surgery (44% vs. 25%, p < 0.001). The CTO lesion length was estimated to be 34 ± 23 mm, mean J-CTO score was 2.9 ± 1.1 and mean PROGRESS-CTO score was 1.4 ± 1.0. A cutting balloon was used in 27%, a scoring balloon in 15%, laser in 14%, rotational atherectomy in 28%, orbital atherectomy in 10%, intravascular lithotripsy in 1% and other modalities/approaches in 5%. Balloon undilatable lesions had lower technical success (90.9% vs. 93.8%, p = 0.007) and higher incidence of major adverse cardiovascular events (MACE) (composite of in-hospital death, acute myocardial infarction, stroke, re-PCI, emergency CABG, and pericardiocentesis) (5.0% versus 1.3%, p < 0.001).
Conclusion:
Approximately 1 in 12 CTO (8.5%) lesions are balloon undilatable. Treatment of balloon undilatable lesions is associated with lower technical success and higher in-hospital MACE.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

